Marijuana penny stocks have corrected this morning, and most are trading red on US and Canadian markets. This morning, Koios Beverage Corp (CSE:KBEV) is booming and is seeing share percentage gains of 100%. Fire & Flower Holdings Corp (TSXV:FAF) is also trading green.

Today, we’ll explore why these two cannabis penny stocks are trending upward, while the rest of the market is falling.

Hemp seeds, or hemp hearts, are the seeds of the hemp plant, or Cannabis sativa. Although marijuana comes from the same plant, hemp seeds only contain a trace amount of THC, the active ingredient in marijuana, and they will not get you high. In fact, hemp seeds are safe and very healthy to eat. Hemp Seeds are a gift of nature. They are the most nutritious seed in the world.

Hemp Seeds are a complete protein. They have the most concentrated balance of proteins, essential fats, vitamins and enzymes combined with a relative absence of sugar, starches and saturated fats.

So much so, analysts at Jefferies says the industry could reach $130 billion by 2029.

“This assumes full U.S. federal legalization, full recreational and medical legalization across Europe, full medical and recreational legalization across Lat Am, and cannabis disruption of a number of other industries,” noted the analysts, as quoted by Yahoo Finance. “Industries at risk of disruption are pharma, alcohol, health and wellness, pet care and smoking cessation.”

The analysts join a growing chorus of cannabis bullishness.

Over the course of the past year, investing in marijuana stocks has proven to be very popular, and in some ways, a lucrative opportunity for long-term gains. Following legalization last year, two of the primary players in the emerging sector are Canopy Growth (TSX:WEED)(NYSE:CGC) and Hexo (TSX:HEXO).

Here’s a review of both companies and which of the two is the better investment for your portfolio right now.

“We are pleased to work with the SQDC and deliver products that will be needed to meet the demand of its customers,” said Tim Emberg, Organigram’s senior vice president of sales and commercial operations, in a release.

The company says Quebec is an important part of Organigram’s national strategy. It will offer consumers in the province a variety of products including mainstream, value and premium flower, along with an assortment of pre-rolls and oils.

“Organigram’s growth strategy has always focused on establishing a strong national footprint and building our brand presence with the Edison Cannabis line nationally,” says Greg Engel, Organigram’s CEO.

A quarter-over-quarter revenue surge powered a Canadian cannabis stock Tuesday. Here’s some small stocks making big moves on Tuesday, February 26, 2019 (as of 11:30 am EST):

48North Cannabis Corp. (TSXV:NRTH), a Canadian cannabis stock, jumped 14% to $1.06 on Tuesday after announcing second-quarter revenue of $2.4 million, an 88% quarter-over-quarter increase.

As well, shares of SunOpta Inc. (TSX:SOY) sank 39% to $3.20 as the organic, non-genetically modified and specialty foods provider said it has fired its President and Chief Executive Officer David Colo.

VIVO Cannabis Inc(OTCMKTS:VVCIF, CVE:VIVO) is not a name that pops up often around the water coolers. But it should.

A provider of medical marijuana, VIVO Cannabis is an overlooked company that reported record third-quarter results, has an active acquisition strategy, maintains a healthy balance sheet, and shows great long-term growth potential.

Investors who are tired of seeing the same cannabis players hogging the spotlight might want to spark up some interest in Vivo Cannabis Inc.

VIVO Cannabis Inc Overview

Formerly known as ABcann Global Corporation, the company changed its name to VIVO Cannabis Inc in August 2018.

Pot stocks aren’t the safest investments to make, as they’re often very volatile and their financials aren’t very consistent. However, one way investors can take advantage of the growing industry without investing directly in cannabis companies is by investing in companies that could benefit from pot but that don’t actually grow it themselves.

A Wall Street bank has officially initiated coverage of cannabis stocks, as high-flying cannabis companies have caught the attention of both the Main Street and Wall Street following a wave of marijuana legalization.

Cannabis stocks had a tumultuous Monday as most pot stocks took a bath in the red.

The North American Marijuana Index, which tracks top cannabis stocks in the US and Canada, was down 0.4% at 288.47.

Duds

There were more duds than buds and Cronos (NASDAQ:CRON) featured high on the list of laggards, shedding 5.9% to $20.63.

The Canadian cannabis company took a hit after Jefferies analyst Owen Bennett kicked off his coverage with an Underperform rating on the stock and a C$17 price target.

CannTrust Holdings (NYSE:CTST) also wasn’t seeing much love on its first day of trading on the New York Stock Exchange, falling 2.3% to $9.66.